Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2025 05:56 ET | Source: Research and Markets

$19 Bn Organ Transplantation Market Analysis by Type of Organ, Product Type, Source of Organs, End-User - Global Forecast to 2030

Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Organ Transplantation Market by Type of Organ, Product Type, Source of Organs, End-User - Global Forecast to 2030" report has been added to ...
May 14, 2024 08:30 ET | Source: Fortress Biotech, Inc.

Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation

Helocyte, a majority-owned subsidiary of Fortress Biotech, is developing Triplex for the prevention and treatment of cytomegalovirus in multiple transplant indications, as well as HIV Clinical trial...
March 17, 2024 09:19 ET | Source: ANERVEA DATA LABS PRIVATE LIMITED

A Groundbreaking Milestone in the Treatment of NASH and Liver Fibrosis - Anervea

Pune, March 17, 2024 (GLOBE NEWSWIRE) -- The recent FDA approval of Resmetirom, developed by Madrigal Pharmaceuticals, has sent ripples of excitement throughout the medical community, marking a...
January 24, 2024 13:25 ET | Source: Persistence Market Research

Liver Transplantation Market at 7.1% CAGR to Reach US$2.4 Billion by 2030, Persistence Market Research

New York, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The global liver transplantation market is projected to experience a compound annual growth rate (CAGR) of 7.1%, translating to an increase from US$ 1.5...
August 11, 2022 08:00 ET | Source: Fortress Biotech, Inc.

Fortress Biotech Subsidiary Helocyte Announces Grant that Could Provide Over $20 Million from National Institute of Allergy and Infectious Diseases for Phase 2 Study of Triplex for Control of Cytomegalovirus in Patients Undergoing Liver Transplantation

MIAMI, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing...